Custom Pharma Services
Private Company
Funding information not available
Overview
Custom Pharma Services is a private, revenue-generating CDMO focused on the contract manufacturing and packaging of small molecule, oral solid dose pharmaceuticals. The company leverages its MHRA-approved UK facility, technical expertise in process engineering, and regulatory savvy to serve clients from technology transfer through commercial launch. Its strategic differentiators include high operational dependability, a full-scope service model, and a partnership with Centrix Pharma Solutions for early-stage development, positioning it as a trusted partner for pharmaceutical companies in Europe.
Technology Platform
Integrated oral solid dose (OSD) contract manufacturing platform specializing in tablets, capsules, caplets, and powders. Capabilities include immediate/modified release formulations, handling of controlled/hormonal drugs, and full-scope services from tech transfer to primary packaging in an MHRA-approved facility.
Opportunities
Risk Factors
Competitive Landscape
Competes in the crowded global and European CDMO market for small molecule oral solid doses. Differentiators include UK/MHRA regulatory focus, niche capabilities with controlled substances, and a partnership for early-stage development. Faces competition from large multinational CDMOs (e.g., Catalent, Lonza) and other regional European specialists.